| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.0009 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.003 |